Ascensia Diabetes Care

Ascensia Diabetes Care develops and commercializes advanced blood glucose monitoring systems and integrated diabetes management solutions. Its CONTOUR® portfolio offers individuals with diabetes accurate, user-friendly devices for tracking blood sugar levels. These systems leverage sophisticated technology, simplifying daily management and empowering patients with data-driven insights.

The company was established in 2016 via the strategic acquisition of Bayer Diabetes Care by PHC Holdings. This created an independent entity singularly focused on the global diabetes community. Robert Schumm played a key role, guiding Ascensia to build upon acquired expertise and product lines, addressing evolving needs of individuals managing diabetes.

Ascensia Diabetes Care serves a worldwide customer base of individuals with diabetes and supporting healthcare professionals. Its vision centers on improving and simplifying the lives of people living with diabetes through reliable, innovative solutions. The company commits to positively impacting daily management and fostering enhanced health outcomes for users.